Medicamen Organics Limited has allotted 27,14,285 fully paid-up equity shares and 11,85,715 warrants convertible into equity shares on a preferential basis for an aggregate issue size of ₹13.65 crore. The Management Committee of the Board of Directors approved the allotment on June 09, 2026, at an issue price of ₹35 per security. The preferential issue was made to promoter Bal Kishan Gupta and non-promoter Pradeep Kumar Jain in accordance with Chapter V of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 (ICDR Regulations).

The equity shares allotted rank pari-passu with the existing equity shares of the company. Consequently, the paid-up share capital of the company increased from ₹12,16,59,100 to ₹14,88,01,950, comprising 1,48,80,195 equity shares of ₹10 each. The allotment includes the conversion of an existing loan into equity shares for the promoter. The company received ₹12,28,74,981 towards the subscription of equity shares and warrants, with the remaining consideration of ₹1,36,25,019 to be received upon the exercise of conversion rights within 18 months.

Breakdown of Allotment

The preferential issue comprised 39,00,000 specified securities. Promoter Bal Kishan Gupta received 1,85,715 convertible warrants and 7,14,285 equity shares. Non-promoter Pradeep Kumar Jain was allotted 10,00,000 convertible warrants and 20,00,000 equity shares.

Post-Allotment Holding

Following the allotment, the shareholding pattern of the allottees has been adjusted. Bal Kishan Gupta holds 46.49% of the company's equity shares, while Pradeep Kumar Jain holds 19.12%.

The equity shares allotted to the investors are locked in for a period specified under Chapter V of the SEBI ICDR Regulations. The company submitted the allotment details in XBRL mode to the stock exchanges.

Medicamen Organics Limited promoter group members, including Bal Kishan Gupta, Ashutosh Gupta, and Ishaan Gupta, confirmed that no encumbrance was created or invoked on the equity shares held by them or any Persons Acting in Concert (PACs) during the financial year ended March 31, 2026. The disclosures, filed under Regulation 31(4) and 31(5) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, cover shareholdings amounting to INR 6,56,85,600, INR 59,14,000, and INR 70,500 respectively.

The declarations were addressed to the Manager-Listing at the National Stock Exchange of India Limited and the Audit Committee of Medicamen Organics . Bal Kishan Gupta, aged 73 years, and Ashutosh Gupta, aged 45 years, provided the confirmations in their capacity as promoters of the company. Ishaan Gupta, aged 19 years and son of Shri Ashutosh Gupta, submitted the declaration as a member of the promoter group.

The filings ensure compliance with the Takeover Regulations, which mandate disclosures regarding any charges or pledges on promoter shareholdings. The confirmations stated that no such encumbrance, whether direct or indirect, was established or triggered during the specified period.

The documents, dated April 07, 2026, were signed by the promoters and submitted for the records of the stock exchange and the company's audit committee.